PAVmed (PAVM) Current Leases (2022 - 2025)

PAVmed's (PAVM) quarterly Current Leases came in at $573000.0 in Q4 2025, up 11.7% year-on-year from $513000.0 in Q4 2024, and up 2.87% quarter-over-quarter from $557000.0 in Q3 2025.

PAVmed (PAVM) Current Leases (2022 - 2025) Analysis & Trends

PAVmed's Current Leases history runs 4 years deep, the most recent figure standing at $573000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 11.7% year-over-year to $573000.0 in Q4 2025; TTM through Dec 2025 was $573000.0, a 11.7% increase from a year earlier, with the FY2025 full-year figure at $573000.0, up 11.7% from the prior year.
  • Current Leases climbed to $573000.0 in Q4 2025 per PAVM's latest filing, from $557000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q3 2023 and bottomed at $513000.0 in Q4 2024.
  • The 4-year median for Current Leases is $985000.0 (2022), against an average of $1.0 million.
  • Across the five-year window, Current Leases jumped 53.26% in 2023 and tumbled 67.22% in 2024, its largest moves.
  • Year by year, Current Leases stood at $1.1 million in 2022, then surged by 37.16% to $1.6 million in 2023, then sank by 67.22% to $513000.0 in 2024, then climbed by 11.7% to $573000.0 in 2025.
  • Per Business Quant, the three latest PAVM Current Leases figures stand at $573000.0 (Q4 2025), $557000.0 (Q3 2025), and $542000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 PAVmed 9.85 Mn -3.35 Mn -4,000.00 573,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 573,000.00
Sep 30, 2025 557,000.00
Jun 30, 2025 542,000.00
Mar 31, 2025 528,000.00
Dec 31, 2024 513,000.00
Sep 10, 2024 865,000.00
Jun 30, 2024 1.37 Mn
Mar 31, 2024 1.33 Mn
Dec 31, 2023 1.57 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.26 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 1.03 Mn
Jun 30, 2022 943,000.00
Mar 31, 2022 873,000.00